Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Remission of diabetes while on sunitinib treatment for renal cell carcinoma.

× No keyword cloud information.

17 in total

1. The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors: Meredith Cummins; Nick Pavlakis
Journal: Ther Adv Med Oncol Date: 2013-09 Impact factor: 8.168

Review 2. Lost in translation: endoplasmic reticulum stress and the decline of β-cell health in diabetes mellitus.

Authors: C Evans-Molina; M Hatanaka; R G Mirmira
Journal: Diabetes Obes Metab Date: 2013-09 Impact factor: 6.577

3. A PKM2 signature in the failing heart.

Authors: Meredith L Rees; Janani Subramaniam; Yuanteng Li; Dale J Hamilton; O Howard Frazier; Heinrich Taegtmeyer
Journal: Biochem Biophys Res Commun Date: 2015-02-28 Impact factor: 3.575

4. Sunitinib and improved diabetes control.

Authors: Helen Elizabeth Jane Tyrrell; Thinn Pwint
Journal: BMJ Case Rep Date: 2014-12-24

Review 5. Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors: Maya B Lodish
Journal: J Clin Endocrinol Metab Date: 2013-02-28 Impact factor: 5.958

6. The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma.

Authors: Anna Maria J Thijs; Cees J Tack; Winette T A van der Graaf; Gerard A Rongen; Carla M L van Herpen
Journal: Br J Clin Pharmacol Date: 2016-01-14 Impact factor: 4.335

7. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.

Authors: D Mokhtari; A Al-Amin; K Turpaev; T Li; O Idevall-Hagren; J Li; A Wuttke; R G Fred; P Ravassard; R Scharfmann; A Tengholm; N Welsh
Journal: Diabetologia Date: 2013-03-05 Impact factor: 10.122

Review 8. Toxicity of Cancer Therapies in Older Patients.

Authors: Olivia Le Saux; Claire Falandry
Journal: Curr Oncol Rep Date: 2018-06-13 Impact factor: 5.075

9. Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro.

Authors: Dariush Mokhtari; Tingting Li; Tao Lu; Nils Welsh
Journal: PLoS One Date: 2011-09-14 Impact factor: 3.240

10. EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.

Authors: Patricia O Prada; Eduardo R Ropelle; Rosa H Mourão; Claudio T de Souza; Jose R Pauli; Dennys E Cintra; André Schenka; Silvana A Rocco; Roberto Rittner; Kleber G Franchini; José Vassallo; Lício A Velloso; José B Carvalheira; Mario J A Saad
Journal: Diabetes Date: 2009-08-20 Impact factor: 9.461